ArticleLaryngoscope investigative otolaryngology2026
The Diagnostic Value of PET/CT and MRI in Head and Neck Cancer of Unknown Primary.
Article in Laryngoscope investigative otolaryngology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Imaging plays a crucial role in the work-up of patients with head and neck cancer of unknown primary (HNCUP). The aim of the present study was to assess the diagnostic value of PET/CT and MRI in patients with clinical HNCUP. Methods: Consecutive patients with clinical HNCUP admitted to Aarhus University Hospital, Denmark, for diagnostic work-up between 2012 and 2017 were included and followed for 5 years. Experts in nuclear medicine and radiology conducted blinded evaluations of PET/CT and MRI scans which were compared to histopathology obtained during primary work-up or subsequent assessment in cases of an emerging primary. A subgroup analysis of patients with clinical HNCUP with lymph node squamous cell carcinoma (HNSCCUP) was performed. Results: A total of 295 clinical HNCUP patients were included. Histopathological diagnoses were squamous cell carcinoma (60%), adenocarcinoma (19%), lymphoma (13%), other cancers (6%), and benign (2%). Detection rates for PET/CT and MRI in clinical HNCUP were 43% and 36% with a sensitivity of 74% and 66%, Conclusion: Our findings support the complementary roles of PET/CT and MRI in the diagnostic work-up of clinical HNCUP. PET/CT tended to detect more primary tumors and may be preferred as the initial imaging modality when only one can be performed, while MRI not only adds value for staging and surgical planning but also helps identify additional primaries, enhancing overall diagnostic precision. Evidence Level: 2b.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.